ML22249A134

Shine Technologies, LLC Final Safety Analysis Report, Chapter 14, Rev. 0, Technical Specifications

ML22249A134
Person / Time
Site:	SHINE Medical Technologies
Issue date:	08/31/2022
From:	SHINE Technologies, SHINE Health. Illuminated
To:	Office of Nuclear Reactor Regulation
Shared Package
ML22249A148	List: ML22249A125 ML22249A126 ML22249A127 ML22249A128 ML22249A129 ML22249A130 ML22249A131 ML22249A132 ML22249A133 ML22249A134 ML22249A135 ML22249A136 ML22249A137 ML22249A138 ML22249A139 ML22249A140 ML22249A141 ML22249A142 ML22249A143 ML22249A144 ML22249A145 ML22249A146
References
2022-SMT-0077
Download: ML22249A134 (6)

Text

TECHNICAL SPECIFICATIONS TABLE OF CONTENTS tion Title Page 1 TECHNICAL SPECIFICATIONS ......................................................................... 14.1-1 2 REFERENCES.................................................................................................... 14.2-1 NE Medical Technologies 14-i Rev. 0

mber Title e

NE Medical Technologies 14-ii Rev. 0

mber Title e

NE Medical Technologies 14-iii Rev. 0

onym/Abbreviation Definition S American Nuclear Society SI American National Standards Institute NE Medical Technologies 14-iv Rev. 0

1 TECHNICAL SPECIFICATIONS SHINE technical specifications were developed following the format and content guidance of erican National Standards Institute/American Nuclear Society (ANSI/ANS) 15.1-2007, The elopment of Technical Specifications for Research Reactors (ANSI/ANS, 2007), and rporating the applicable guidance of NUREG-1537, Parts 1 and 2 (USNRC, 1996a; USNRC, 6b) and the Interim Staff Guidance Augmenting NUREG-1537, Parts 1 and 2 (USNRC, 2a; USNRC, 2012b). Normal operation of the SHINE facility within the limits of the technical cifications will not result in offsite radiation exposure in excess of 10 CFR Part 20 guidelines.

ervance of these technical specifications limits the likelihood and consequences of functions.

NE Medical Technologies 14.1-1 Rev. 0

SI/ANS, 2007. The Development of Technical Specifications for Research Reactors, erican National Standards Institute, ANSI/ANS-15.1, 2007.

NRC, 1996a. Guidelines for Preparing and Reviewing Applications for the Licensing of

-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory mmission, February 1996.

NRC, 1996b. Guidelines for Preparing and Reviewing Applications for the Licensing of

-Power Reactors: Standard Review Plan and Acceptance Criteria, NUREG-1537, Part 2,

. Nuclear Regulatory Commission, February 1996.

NRC, 2012a. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for paring and Reviewing Applications for the Licensing of Non-Power Reactors: Format and tent, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous ctors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory mmission, October 27, 2012.

NRC, 2012b. Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for paring and Reviewing Applications for the Licensing of Non-Power Reactors: Standard iew Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and eous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 2,

. Nuclear Regulatory Commission, October 27, 2012.

NE Medical Technologies 14.2-1 Rev. 0